Dr. Kunal Suryawala, MD

Dr. Suryawala practices at NCH Baker Hospital in Naples, Florida, part of NCH Healthcare System.

Dr. Suryawala's NPI, 1326365289, was assigned on April 30, 2010. Dr. Suryawala graduated from Ross University School of Medicine in 2009. Dr. Suryawala holds Florida license ME127721.

Dr. Suryawala's primary practice is NCH Baker Hospital, at 350 7th St N, Naples, FL 34102 in Collier County. The practice phone is (239) 624-5000.

Dr. Suryawala's primary practice is NCH Baker Hospital in Naples, Florida, part of NCH Healthcare System. The medical group on file is NCH Medical Group - Hospitalists. Dmand AI also links Dr. Suryawala to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suryawala practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Suryawala's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Suryawala is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Suryawala's licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Suryawala treats.

CMS data shows 1,634 Medicare services from Dr. Suryawala across 17 procedure codes in 2024, for 773 Medicare patients. Medicare paid $180,128 for them.

CMS counts 773 Medicare patients who saw Dr. Suryawala in 2024. The largest group is 75 to 84, with 360 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Suryawala's median patient age at 66, with 50% women.

In 2024, Dr. Suryawala wrote 2,024 Medicare Part D claims for 769 patients. 89% of them were for generic drugs. CMS names the drug for 1,888 of them, across 29 drugs with 11 or more claims each, at $273,083 in total drug cost. In 2023, CMS named 1,641 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Suryawala for performance year 2024, reported through an alternative payment model (APM). Dr. Suryawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 280 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Suryawala, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Suryawala. Dr. Suryawala's most frequent co-authors are Avinash Aravantagi, MD, Moheb Nabil Boktor and Paul Alexander Jordan, MD.

CMS Open Payments shows 72 general payments to Dr. Suryawala from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $508.

Dr. Suryawala graduated from Ross University School of Medicine in 2009.

Dr. Suryawala is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.